Astera Labs Earnings: A 50/50 Setup Investors Should Question
Astera Labs shows strong growth but faces questions about pricing power and capex demand. Read why I downgrade ALAB stock from buy to hold.
Astera Labs, Inc. (ALAB) Receives a Rating Update from a Top Analyst
J.P. Morgan analyst Harlan Sur maintained a Buy rating on Astera Labs, Inc. (ALAB – Research Report) today and set a price target of $130.00.
Astera Labs, Inc. Common Stock (NASDAQ:ALAB) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript February 11, 2025 Operator: Hello. Good afternoon. My name is Joe, and I will be your conference operator today. At this time, I would like to welcome everyone to the Astera Labs Q4 ‘24 Earnings Call.
ALAB Stock Before Q4 Earnings: A Smart Buy or Risky Investment?
Astera Labs ALAB is scheduled to report fourth-quarter 2024 results on Feb. 10. Find the latest EPS estimates and surprises on Zacks Earnings Calendar. For the fourth quarter of 2024, the company expects revenues between $126 million and $130 million.
Astera Labs, Inc. (ALAB) Receives a Buy from Northland Securities
Northland Securities analyst Gus Richard maintained a Buy rating on Astera Labs, Inc. (ALAB – Research Report) today and set a price target of
Astera Labs, Inc. (ALAB): One of January’s Biggest Losers
We recently published a list of 15 Stocks That Took a Nosedive in January. In this article, we are going to take a look at where Astera Labs, Inc. (NASDAQ:ALAB) stands against other stocks that took a nosedive in January.
Astera Labs' AI prowess continues to shine, analysts say
Astera Labs (NASDAQ:ALAB) has firmly cemented itself as a beneficiary of the artificial intelligence spending boom, as evidenced by its latest quarterly results, according to Wall Street. And there is likely more to come on that front.
What's Going On With Astera Labs Stock Tuesday?
Astera Labs Inc (NASDAQ:ALAB) shares are trading lower Tuesday on the heels of the company's fourth-quarter financial results ...
Astera Labs Q4: Strong Finish, Stronger Outlook, Excessive Dilution
Astera Labs reported a strong Q4, beating revenue expectations by 10% and tripling its earnings per share. Find out why I ...
Stratos Wealth Partners LTD. Lowers Stake in Astera Labs, Inc. (NASDAQ:ALAB)
Stratos Wealth Partners LTD. trimmed its stake in Astera Labs, Inc. (NASDAQ:ALAB – Free Report) by 16.0% in the 4th quarter, ...
Astera Labs price target raised to $125 from $105 at Craig-Hallum
Craig-Hallum raised the firm’s price target on Astera Labs (ALAB) to $125 from $105 and keeps a Buy rating on the shares. Astera had “another ...